TuisBOT • ASX
add
Botanix Pharmaceuticals Ltd
Vorige sluiting
$0,36
Dagwisseling
$0,34 - $0,36
Jaarwisseling
$0,14 - $0,45
Markkapitalisasie
591,85 m AUD
Gemiddelde volume
5,67 m
P/V-verhouding
-
Dividend-opbrengs
-
Primêre beurs
ASX
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (AUD) | Jun. 2024info | J/J-verandering |
|---|---|---|
Inkomste | 845,78 k | 2 753,22% |
Bedryfskoste | 3,74 m | 90,08% |
Netto inkomste | -4,20 m | -84,39% |
Netto winsgrens | -496,73 | 93,54% |
Wins per aandeel | — | — |
EBITDA | -4,20 m | -86,54% |
Effektiewe belastingkoers | — | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (AUD) | Jun. 2024info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 79,31 m | 673,71% |
Totale bates | 112,46 m | 352,83% |
Totale aanspreeklikheid | 3,73 m | 97,99% |
Totale ekwiteit | 108,73 m | — |
Uitstaande aandele | 1,81 mjd | — |
Prys om te bespreek | 5,92 | — |
Opbrengs op bates | -9,41% | — |
Opbrengs op kapitaal | -9,73% | — |
Kontantvloei
Netto kontantverandering
| (AUD) | Jun. 2024info | J/J-verandering |
|---|---|---|
Netto inkomste | -4,20 m | -84,39% |
Kontant van bedrywe | -2,18 m | 31,16% |
Kontant van beleggings | -1,61 m | -66,06% |
Kontant van finansiering | 34,17 m | 620,67% |
Netto kontantverandering | 30,50 m | 3 874,53% |
Beskikbare kontantvloei | -2,78 m | -42,87% |
Meer oor
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
Gestig
1984
Webwerf
Werknemers
11
